Drugs / VARICELLA-ZOSTER IMMUNE GLOBULIN
VARICELLA-ZOSTER IMMUNE GLOBULIN
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase not stated1 trial | ||||||
| — | NCT00338442 | Feb 2006 → Dec 2009 | chickenpox | Cangene Corporation | Approved for marketing | No outcome recorded |
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT06068608 Comparator | Sep 2023 → Dec 2024 | chickenpox | Zhuhai Trinomab Pharmaceutical Co., Ltd. | Unknown | No outcome recorded |
Press releases naming this drug 3 releases
| Date | Issuer | Release |
|---|---|---|
| 2025-01-22 | Kamada, Ltd. | Kamada Announces a $25 Million 3-Year Contract for Supply of KAMRAB® and VARIZIG® in Latin America kamada.com ↗ |
| 2022-07-06 | Kamada, Ltd. | Kamada Announces $11.4 Million International VARIZIG® Procurement Agreement kamada.com ↗ |
| 2019-01-11 | Saol Therapeutics Inc | Saol Therapeutics Announces that CDC Website has Been Updated to Reflect Wide Availability of VARIZIG® (Varicella Zoster Immune Globulin [Human]) saolrx.com ↗ |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 4 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | VARICELLA-ZOSTER IMMUNE GLOBULIN | ChEMBL registry synonym — accepted as the source's own label CHEMBL2108828 ↗ |
| Known as | varicella zoster immune globulin (human) | “Varicella zoster immune globulin (human) (VARIZIG) is recommended for post-exposure prophylaxis to prevent or attenuate varicella infection in high-risk individuals.” PMID 33430796 ↗ Jan 2021 |
| Known as | VARIZIG | “Varicella zoster immune globulin (human) (VARIZIG) is recommended for post-exposure prophylaxis to prevent or attenuate varicella infection in high-risk individuals.” PMID 33430796 ↗ Jan 2021 |
| Modality | Protein / enzyme biologic | “VariZIG™, which is a purified human immune globulin preparation made from plasma of donors with high anti-varicella antibody titers.” NCT00338442 ↗ |
| Route | Intramuscular | “a single dose of VARIZIG 625 IU,intramuscular injection” NCT06068608 ↗ |